New Solution for Cancer Therapy from Siemens

Siemens HealthcareOne of Siemens Healthcare's highlights of this year's Conference of the European Society for Therapeutic Radiology and Oncology (ESTRO) is IM-RealART™ Solution for adaptive radiotherapy. With IM-RealART, treatment plans for radiotherapy can be adapted especially fast to changes in the shape and position of tumors. The treatment plan is revised even while the patient is still lying on the treatment table. This means that the radiation fields and dose are recalculated directly before the next fraction is irradiated.

With IM-RealART, Siemens Healthcare offers a new solution for especially fast replanning of treatment plans in adaptive radiotherapy. The solution includes the Siemens products Artiste™ Solution (linear accelerator), the 550TxT™ treatment table, the CTVision™ System for diagnostic CT (computed tomography) imaging and the RealART™ planning system from Prowess Inc.

One of the special advantages of IM-RealART is CTVision. Using this system, top quality "gold standard" images of tumors can be taken directly in the treatment room using a CT scanner running on rails. While the patient lies immobilized on the treatment table, the current scans are compared to the original ones on which the treatment planning was based and evaluated.

If the shape of the tumor has changed, the treatment plan can be adapted immediately in order to correct the shape of the treatment radiation field as well as the dose. This recalculation is usually performed in just seven minutes. Since the patient's position is not changed during this period, it is possible to irradiate the tumor with high precision. Using the 160MLC™ multileaf collimator from Siemens, the radiation field can be confined to the tumor very precisely, thus saving the surrounding tissue.

IM-RealART can be combined with the Siemens solution IM-Confident™ Plan, which consists of Artiste with the 160MLC and an intelligent irradiation planning software. These components help reduce the treatment time required for intensity-modulated radiation therapy (IMRT) to five minutes or even less.

IM-RealART and IM-Confident from Siemens offer two solutions which, on the one hand, make daily workflows in radiooncology much simpler and more efficient while, at the same time, enabling high precision patient treatment: Using innovative technologies, the tumor is irradiated with pinpoint accuracy while the latest software and imaging ensure that planning, replanning and therapy all proceed as swiftly as possible. This corresponds to Siemens' philosophy for radiotherapy: To achieve rapid and precise treatment while sparing the patient undue discomfort.

Related news articles:

About Siemens Healthcare Sector
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens is the only company to offer customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 49,000 employees worldwide and operates in over 130 countries. In fiscal year 2008 (to September 30), the Sector posted revenue of 11.2 billion euros and profit of 1.2 billion euros. For further information please visit: www.siemens.com/healthcare.

Most Popular Now

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...

New Recommendations to Increase Transpar…

Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally-agreed recommendations are followed. A new set of recommendations published in The...

Digital Health Unveils Draft Programme f…

18 - 19 March 2025, Birmingham, UK. Digital Health has unveiled the draft programme for its Rewired 2025 event which will take place at the NEC in Birmingham in March next...

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...